Skip to main content
. 2022 Mar 15;6(2):e12676. doi: 10.1002/rth2.12676

TABLE 1.

Effect of anticoagulants on tests used to investigate lupus anticoagulant (LA) as well as other routine coagulation tests

Anticoagulant aPTT SCT dRVVT PT TT Anti‐Xa assay
Unfractionated heparin ↑–↑↑↑ (concentration dependent; most reagents do not contain neutralizer)

↔ (up to ~1 U/ml if contains heparin neutralizer)

↑ (if exceeds or no neutralizer)

↔ (up to ~1 U/ml if contains heparin neutralizer)

↑ (if exceeds neutralizer)

↔ (up to ~1 U/ml if contains heparin neutralizer)

↑ (if exceeds neutralizer)

↑↑↑ ↑–↑↑↑ (concentration dependent)
LMWH

↔ (if contains heparin neutralizer)

↑ (if no neutralizer)

↔ (if contains heparin neutralizer) ↔ (if contains heparin neutralizer) ↑–↑↑↑ (concentration dependent)
VKAs ↑↑ ↑↑↑
Dabigatran ↑↑ ↑↑ ↑↑↑
Rivaroxaban ↑↑ ↑↑↑ ↑↑ ↑↑↑
Apixaban ↔–↑ (assay dependent) ↑ (but LA ratio may fall because effect greater on confirmed reagents) ↔–↑ (assay dependent) ↑↑↑
Edoxaban ↔–↑ (assay dependent) ↔–↑ (assay dependent) ↑↑↑

↑, prolongs (the more ↑, the greater the prolongation); ↔, no effect.

Abbreviations: aPTT, activated partial thromboplastin time; dRVVT, dilute Russell's viper venom time; LMWH, low molecular weight heparin; PT, prothrombin time; SCT, Silica clotting time; TT, thrombin time; VKA, vitamin K agonist.